North4000 - re Ocata
I am shocked/surprised that nobody seems to be interested in this stock. Given the safety and early efficacy observed in the 38-43 patients, anecdotal evidence on internet, Lancet journal publication, patent position etc, possibility to own the eye amd market its just crazy.
I know that my biotech knowledge is close to zero...not sure about yours...however i was hoping that some here would shed some light and make some pro and con commentary about the investment potential and scientific merit.
Unless the idea comes from Dewgiligence, jq, biomaven and a few others...most are not interested from the gate.
While i question my understanding of the science , i feel that the lack of interest from this board is almost a negative for owning the stock....and i resigned myself to just post info gleaned on other boards in case some find it usefull here
